-
Mercayon applied to FDA to expand the HPV vaccine Gardasil to prevent pharynx cancer in both men and women
Time of Update: 2020-06-25
MSD applied to U.S regulators to expand the human papillomavirus (HPV) vaccine Gardasil's indications to prevention of oral and other throat cancers and other head and neck cancers caused by type
-
Truxima, Reinadoamine and acalabrutinib treatment for relapsed invasive invasive B-cell lymphoma: safe and effective
Time of Update: 2020-06-25
Data from the 25th EHA Virtual Conference showed that Truxima ® (biosimilar rituximab) combined with the nadoamine and acalabrutinib (R2A) protocol to treat recurrent refractory invasive B cells ly
-
1 case of tibia cartilage sarcoma and literature review
Time of Update: 2020-06-25
Cartilon sarcoma is the incidence of the incidence after osteosarcoma of the primary bone malignant tumor, accounting for about 20% of all malignant bone tumors, often in the pelvis, femur ends, the
-
FDA grants ONIVYDE fast-track designation for first-line combination therapy for metastatic pancreatic cancer
Time of Update: 2020-06-25
Epson announced that the U.S Food and Drug administration Administration ( FDA ) has granted fast-track designations for its Ilition lipids (ONIVYDE) for use in conjunction with 5-fluoruric preur
-
Cell Rep Med: Targeting the COVID-19 vaccine using cancer immunotherapy tools
Time of Update: 2020-06-22
, June 18, 2020 /PRNewswire bioON, , researchers at the Children's Hospital of Cancer Philadelphia (CHOP) used tools used to develop cancer immunotherapy to make them suitable for identifying vaccine
-
Good news! Good vitamin D status can prevent cancer!
Time of Update: 2020-06-21
, June 18, 2020 /PRNewswire- bio-valley, , says good vitamin D status is beneficial for cancer prevention and prognosis for several types of cancer, according to a new study The anti-cancer effects
-
Application of robot minimally invasive Ivor Lewis esophagectomy
Time of Update: 2020-06-19
cited this article: Zhang Yajie, Han Yu, Jie Jie, Li Hecheng Application of robot minimally invasive Ivor Lewis radical esophagectomy China's thoracic and cardiovascular surgery clinical journal,
-
Immunotherapy of glioma
Time of Update: 2020-06-19
In the past decade, immunotherapy has been used more and more in solid tumors, including melanoma, lung cancer, breast cancer, prostate cancer, bladder cancer and kidney cancer, but the treatment of g
-
Science: review of metabolic remodeling and cancer progress
Time of Update: 2020-06-19
Translation: scopolamine, editing: Xie Yi, Jiang shunyao metabolic remodeling (also known as metabolic reprogramming) is a characteristic of malignant tumors With the increasing unde
-
Summary: difficulties and key points of PD-L1 immunohistochemistry
Time of Update: 2020-06-19
PD-L1 is a transmembrane protein expressed on T cells, B cells and tumor cells The study shows that when PD-L1 on tumor cell membrane combines with PD-1 on T cells and other immune cells, tum
-
A review of the weight study of advanced | liver cancer in ASCO
Time of Update: 2020-06-19
China's primary liver cancer patients account for more than 50% of the world's primary liver cancer (HCC) patients earl
-
ASCO: a summary of the latest research progress of three negative breast cancer (TNBC) targeting drugs
Time of Update: 2020-06-19
The expression of estrogen receptor (ER), progesterone receptor (PR) and proto oncogene human epidermal growth factor receptor (HER2) was negative, accounting for 15% - 20% of all breast cancer types
-
In 2020, Huada gene oncology medical achievements show: 3 latest cancer detection technologies to help cancer prevention and control
Time of Update: 2020-06-19
on May 29, 2020, at the "panoramic sequencing cancer prevention and control -- 2020 Huada gene tumor technology research and conference" held by Shenzhen Huada gene Co., Ltd
-
The latest research progress of CRISPR / CAS in May 2020
Time of Update: 2020-06-19
CRISPR is the abbreviation of regularly spaced short palindrome repeats, and CAS is the abbreviation of CRISPR related proteins CRISPR / CAS was originally found in bacteria
-
Selected Compilation: Artificial Intelligence Deep Learning Analysis Of Multimodal Imaging Features To Predict Brain Tumors...
Time of Update: 2020-06-17
Glioma is a common primary malignant brain tumor, precise molecular type is very important for the diagnosis, treatment and identification of risk factors and prognosis Li Sun of the School of Innovat
-
First-line immunotherapy for bladder cancer! Mercadon Keytruda (Corrida) Joint Standard Care Chemotherapy First Line Treatment Phase III Clinical Failure!
Time of Update: 2020-06-17
, June 10, 2020 / BIOON/ BiovalleyS/Merck and Co recently announced the results of the Third Under-361 Study (NCT02853305) The study is evaluating anti-PD-1 therapy Keytruda (Corrida, generic name: p
-
Esophageal cancer immunotherapy! Opdivo (Odivo) was approved in Taiwan, China, and, regardless of PD-L1 status, significantly extends its lifetime!
Time of Update: 2020-06-17
esophageal cancer (photo: medindia.net) June 07, 2020 / Bio Valley BIOON / - Japanese drugmaker Ono Pharma recently announced that its Taiwan subsidiary Ono Pharma Taiwan (OPTW) has received the T
-
Cell: Wall cell integrators regulate cancer cell communication to control the cancer burden!
Time of Update: 2020-06-17
, June 9, 2020 / PRNewswire/ -- An increase in the formation of bio-valley BIOON /- Blood vessels (BV) is thought to drive tumor growth by increasing nutrient delivery However, this observation ign
-
The administration is only 3-5 minutes! Johnson and Johnson Darzalex (megazo ®) subcutaneous preparation has been approved by the European Union: the first myeloma subcutaneous CD38 target anti-cancer drug!
Time of Update: 2020-06-17
, 2020 / PRNewswire/ -- The European Commission (EC) recently approved The Johnson and Johnson (JNJ) heavy myeloma drug Darzalex ,®, generic name: daratumab, Darree Subcutaneous (SC) preparations f
-
Nat Med: Study reveals factors that influence immune outcomes for kidney cancer
Time of Update: 2020-06-17
, June 10, 2020 /PRNewswire/ -- Scientists at the Biovalley BIOON /-- By analyzing tumors in patients with advanced kidney cancer who received immunotherapy in three clinical trials , scientists h
